AMLODIPINE AND VALSARTAN (amlodipine and valsartan) by Cadila Pharmaceuticals Limited: new human prescription drug listing
AMLODIPINE AND VALSARTAN: new human prescription drug listing. Dated 14 days ago, it is in the active follow-up window. Score 65/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 12 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Product | AMLODIPINE AND VALSARTAN |
| Generic name | amlodipine and valsartan |
| NDC | 71209-024 |
| Labeler | Cadila Pharmaceuticals Limited |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | ANDA |
| Application number | ANDA205797 |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 320 mg/1 |
| Marketing start | 2026-10-22 |
| Package configurations | 2 |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch AMLODIPINE AND VALSARTAN
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock AMLODIPINE AND VALSARTAN + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-10-22
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (HUMAN PRESCRIPTION DRUG first): Cyclophosphamide by Amneal Pharmaceuticals LLC · Cyclophosphamide by Amneal Pharmaceuticals LLC · YESAFILI (aflibercept-jbvf) by Biocon Biologics Inc. · CIPROFLOXACIN OTIC (ciprofloxacin) by Alembic Pharmaceutical · WELTRUZA (olanzapine) by Teva Pharmaceuticals USA, Inc. · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: AMLODIPINE AND VALSARTAN and 1,345 HUMAN PRESCRIPTION DRUG peers
- HUMAN PRESCRIPTION DRUG FdaNdcDirectoryPulse records like this one: 1,345
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every HUMAN PRESCRIPTION DRUG peer: $269,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Launch Signal Score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.
What is the FdaNdcDirectoryPulse record for AMLODIPINE AND VALSARTAN?
AMLODIPINE AND VALSARTAN by Cadila Pharmaceuticals Limited: new human prescription drug listing (ANDA) starting 2026-10-22.
How does AMLODIPINE AND VALSARTAN compare to other FdaNdcDirectoryPulse records?
It is fresh: dated 14 days ago, inside the window where early outreach matters most.
AMLODIPINE AND VALSARTAN vs. top 3 peers
| Organization | Location | Record date |
|---|---|---|
| AMLODIPINE AND VALSARTAN | HUMAN PRESCRIPTION DRUG | 2026-10-22 |
| YESAFILI | HUMAN PRESCRIPTION DRUG | 2026-11-03 |
| LEROCHOL | HUMAN PRESCRIPTION DRUG | 2026-11-01 |
| CAMCEVI ETM | HUMAN PRESCRIPTION DRUG | 2026-10-31 |
Related records
FdaNdcDirectoryPulse: Prescription (Rx) FdaNdcDirectoryPulse: Generic (ANDA)
How to monitor AMLODIPINE AND VALSARTAN and peer generic (anda) records
Get new FdaNdcDirectoryPulse records like AMLODIPINE AND VALSARTAN by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.